Zobrazeno 1 - 10
of 26
pro vyhledávání: ''
Publikováno v:
Drug Design, Development and Therapy
Xiangxun Chen, Mengxi Zhou, Wenjie Fan, Mingwei Yang, Lin Yang Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, People’s Republic of ChinaCorrespondence: Lin YangDepartment of Radiati
Publikováno v:
Drug Design, Development and Therapy. 12:3043-3049
Xiaofei Li,1 Jia Wan,2 Zhenping Wu,3 Juncai Tu,1 Yongtao Hu,1 Shuang Wu,1 Lianqing Lou1 1Department of Infectious Diseases, Yiwu Central Hospital, Yiwu, China; 2The First Hospital of Nanchang, Nanchang, China; 3Gastroenterology Department, Jinhua Cen
Publikováno v:
Drug Design, Development and Therapy
Si Li,1,* Wei Wei,1,* Yi Jiang,1 Qiuyun Li,1 Qinghua Huang,1 Huawei Yang,1 Jianlun Liu1,2 1Department of Breast Surgery, The Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi, China; 2Department of General Surgery, Longdong Ho
Publikováno v:
Drug Design, Development and Therapy
Qifang Long, Weipei Zhu, Liangsheng Guo, Li Pu Department of Gynecology and Obstetrics, The Second Affiliated Hospital of Soochow University, Suzhou, People’s Republic of ChinaCorrespondence: Weipei Zhu Email weipeizhu@163.comBackground: To establi
Publikováno v:
Drug Design, Development and Therapy
Na Yin, Hui Yu, Xiaodi Zhang, Xiaodan Lv Department of Pharmacy, Jinan Infectious Diseases Hospital Affiliated to Shandong University, Jinan 250000, People’s Republic of ChinaCorrespondence: Xiaodan LvJinan Infectious Diseases Hospital, No. 22029 J
Publikováno v:
Drug Design, Development and Therapy
Ruosi Yao,1,2 Yu Xie,1 Xiaoyang Sun,1 Menghui Zhang,1 Jian Zhou,1 Linlin Liu,3 Jian Gao,4 Kailin Xu1,2 1Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, People’s Republic of China; 2Department of Hematology, The Affiliated Hosp
Publikováno v:
Drug Design, Development and Therapy
Advanced cutaneous T cell lymphomas (CTCL) including mycosis fungoides (MF) and Sézary syndrome (SS) are often difficult to manage once they become resistant to initial systemic treatment. Current systemic treatments usually provide a limited durati
Autor:
Diwakar Davar, Saro Sarkisian
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 12, Pp 2553-2565 (2018)
Drug Design, Development and Therapy
Drug Design, Development and Therapy
Saro Sarkisian,1 Diwakar Davar2 1Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA; 2Division of Hematology-Oncology, Hillman Cancer Center and University of Pittsburgh, Pittsburgh, PA, USA Abstract: Melanoma is inc
Autor:
Yan Liu, Wendu Duan
Publikováno v:
Drug Design, Development and Therapy
Wendu Duan, Yan Liu Department of Hepatobiliary Surgery, Affiliated Hospital of Hebei University, Baoding, Hebei Province 071000, People’s Republic of China Purpose: Targeted hepatocellular carcinoma therapy was carried out to improve the efficacy
Publikováno v:
Drug Design, Development and Therapy
Rossella De Luca,1 Livio Blasi,2 Massimiliano Alù,2 Valerio Gristina,1 Giuseppe Cicero1 1Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy; 2Medical Oncology Unit, ARNAS Hospita